Boothbay Fund Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36,900	Closed	-$2.65M	–	1733
2023 Q2	$2.65M	Buy	36,900 +5,600	+18%	+$413K	0.08%	445
2023 Q1	$1.93M	Sell	31,300 -109,600	-78%	-$7.2M	0.05%	683
2022 Q4	$10.9M	Sell	140,900 -1,000	-0.7%	-$59.8K	0.33%	57
2022 Q3	$6.33M	Sell	141,900 -141,100	-50%	-$7.05M	0.2%	121
2022 Q2	$10.8M	Sell	283,000 -86,600	-23%	-$2.74M	0.34%	43
2022 Q1	$15.3M	Buy	369,600 +208,300	+129%	+$6.46M	0.46%	31
2021 Q4	$6.09M	Buy	161,300 +56,800	+54%	+$2.09M	0.19%	160
2021 Q3	$3.44M	Buy	+104,500	New	+$4.07M	0.13%	257
2020 Q2	–	Sell	-113	Closed	-$665K	–	974
2020 Q1	$665K	Buy	113 +68	+151%	+$5.54K	0.07%	399
2019 Q4	$465K	Buy	+45	New	+$1.82K	0.05%	507